https://stock.noler.com/us/stock/arno-therapeutics-inc https://stock.noler.com/us/stock/arno-therapeutics-inc/accounts-payable https://stock.noler.com/us/stock/arno-therapeutics-inc/accounts-payable-and-accrued-liabilities-noncurrent https://stock.noler.com/us/stock/arno-therapeutics-inc/accumulated-depreciation https://stock.noler.com/us/stock/arno-therapeutics-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/arno-therapeutics-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/arno-therapeutics-inc/additional-paid-in-capital https://stock.noler.com/us/stock/arno-therapeutics-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/arno-therapeutics-inc/amended-reports-10-k https://stock.noler.com/us/stock/arno-therapeutics-inc/amended-reports-10-q https://stock.noler.com/us/stock/arno-therapeutics-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/arno-therapeutics-inc/amortization-of-financing-costs https://stock.noler.com/us/stock/arno-therapeutics-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/arno-therapeutics-inc/basic-shares https://stock.noler.com/us/stock/arno-therapeutics-inc/capital-expenditures https://stock.noler.com/us/stock/arno-therapeutics-inc/capital-lease-obligations-current https://stock.noler.com/us/stock/arno-therapeutics-inc/capital-lease-obligations-noncurrent https://stock.noler.com/us/stock/arno-therapeutics-inc/capital-leased-assets-gross https://stock.noler.com/us/stock/arno-therapeutics-inc/capital-leases-future-minimum-payments-due https://stock.noler.com/us/stock/arno-therapeutics-inc/capital-leases-future-minimum-payments-due-current https://stock.noler.com/us/stock/arno-therapeutics-inc/capital-leases-future-minimum-payments-due-in-three-years https://stock.noler.com/us/stock/arno-therapeutics-inc/capital-leases-future-minimum-payments-due-in-two-years https://stock.noler.com/us/stock/arno-therapeutics-inc/capital-leases-future-minimum-payments-interest-included-in-payments https://stock.noler.com/us/stock/arno-therapeutics-inc/capital-leases-future-minimum-payments-present-value-of-net-minimum-payments https://stock.noler.com/us/stock/arno-therapeutics-inc/cash-and-equivalents https://stock.noler.com/us/stock/arno-therapeutics-inc/cash-flow-breakdown https://stock.noler.com/us/stock/arno-therapeutics-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/arno-therapeutics-inc/class-of-warrant-or-right-number-of-securities-called-by-each-warrant-or-right https://stock.noler.com/us/stock/arno-therapeutics-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/arno-therapeutics-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/arno-therapeutics-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/arno-therapeutics-inc/common-stock-dividends-shares https://stock.noler.com/us/stock/arno-therapeutics-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/arno-therapeutics-inc/common-stock-shares-subscribed-but-unissued https://stock.noler.com/us/stock/arno-therapeutics-inc/common-stock-shares-subscriptions https://stock.noler.com/us/stock/arno-therapeutics-inc/common-stock-value https://stock.noler.com/us/stock/arno-therapeutics-inc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/arno-therapeutics-inc/convertible-debt https://stock.noler.com/us/stock/arno-therapeutics-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/arno-therapeutics-inc/current-assets https://stock.noler.com/us/stock/arno-therapeutics-inc/current-liabilities https://stock.noler.com/us/stock/arno-therapeutics-inc/debt-carrying-amount https://stock.noler.com/us/stock/arno-therapeutics-inc/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/arno-therapeutics-inc/debt-conversion-converted-instrument-shares-issued https://stock.noler.com/us/stock/arno-therapeutics-inc/debt-convertible-beneficial-conversion-feature https://stock.noler.com/us/stock/arno-therapeutics-inc/debt-convertible-conversion-price https://stock.noler.com/us/stock/arno-therapeutics-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/arno-therapeutics-inc/deferred-finance-costs-noncurrent-net https://stock.noler.com/us/stock/arno-therapeutics-inc/deferred-rent-credit-current https://stock.noler.com/us/stock/arno-therapeutics-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/arno-therapeutics-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/arno-therapeutics-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/arno-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/arno-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards-domestic https://stock.noler.com/us/stock/arno-therapeutics-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/arno-therapeutics-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/arno-therapeutics-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/arno-therapeutics-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/arno-therapeutics-inc/defined-contribution-plan-employer-matching-contribution-percent https://stock.noler.com/us/stock/arno-therapeutics-inc/deposits-assets-noncurrent https://stock.noler.com/us/stock/arno-therapeutics-inc/depreciation https://stock.noler.com/us/stock/arno-therapeutics-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/arno-therapeutics-inc/derivative-liabilities-noncurrent https://stock.noler.com/us/stock/arno-therapeutics-inc/development-stage-enterprise-deficit-accumulated-during-development-stage https://stock.noler.com/us/stock/arno-therapeutics-inc/diluted-shares https://stock.noler.com/us/stock/arno-therapeutics-inc/dilutive-securities https://stock.noler.com/us/stock/arno-therapeutics-inc/dilutive-shares https://stock.noler.com/us/stock/arno-therapeutics-inc/dividends-common-stock-cash https://stock.noler.com/us/stock/arno-therapeutics-inc/due-to-related-parties-current https://stock.noler.com/us/stock/arno-therapeutics-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/arno-therapeutics-inc/effective-tax-rate https://stock.noler.com/us/stock/arno-therapeutics-inc/embedded-derivative-fair-value-of-embedded-derivative-asset https://stock.noler.com/us/stock/arno-therapeutics-inc/employee-related-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/arno-therapeutics-inc/eps https://stock.noler.com/us/stock/arno-therapeutics-inc/eps-basic https://stock.noler.com/us/stock/arno-therapeutics-inc/equity-issuance-per-share-amount https://stock.noler.com/us/stock/arno-therapeutics-inc/expense-related-to-distribution-or-servicing-and-underwriting-fees https://stock.noler.com/us/stock/arno-therapeutics-inc/fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/arno-therapeutics-inc/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/arno-therapeutics-inc/fair-value-assumptions-weighted-average-volatility-rate https://stock.noler.com/us/stock/arno-therapeutics-inc/fair-value-measurement-with-unobservable-inputs-reconciliations-recurring-basis-liability-value https://stock.noler.com/us/stock/arno-therapeutics-inc/fair-value-of-assets-acquired https://stock.noler.com/us/stock/arno-therapeutics-inc/financing-cash-flow https://stock.noler.com/us/stock/arno-therapeutics-inc/form-d-other https://stock.noler.com/us/stock/arno-therapeutics-inc/furniture-and-fixtures-gross https://stock.noler.com/us/stock/arno-therapeutics-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/arno-therapeutics-inc/general-and-administrative-expense https://stock.noler.com/us/stock/arno-therapeutics-inc/impairment-of-intangible-assets-indefinitelived-excluding-goodwill https://stock.noler.com/us/stock/arno-therapeutics-inc/income-tax https://stock.noler.com/us/stock/arno-therapeutics-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/arno-therapeutics-inc/income-tax-expense-benefit https://stock.noler.com/us/stock/arno-therapeutics-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/arno-therapeutics-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/arno-therapeutics-inc/increase-decrease-in-deferred-charges https://stock.noler.com/us/stock/arno-therapeutics-inc/increase-decrease-in-due-to-related-parties https://stock.noler.com/us/stock/arno-therapeutics-inc/increase-decrease-in-other-receivables https://stock.noler.com/us/stock/arno-therapeutics-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/arno-therapeutics-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/arno-therapeutics-inc/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/arno-therapeutics-inc/increase-decrease-in-security-deposits https://stock.noler.com/us/stock/arno-therapeutics-inc/incremental-common-shares-attributable-to-call-options-and-warrants https://stock.noler.com/us/stock/arno-therapeutics-inc/insider-transactions-corporate-securities https://stock.noler.com/us/stock/arno-therapeutics-inc/insider-transactions-other https://stock.noler.com/us/stock/arno-therapeutics-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/arno-therapeutics-inc/insider-transactions-warrants https://stock.noler.com/us/stock/arno-therapeutics-inc/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/arno-therapeutics-inc/insider-transactions-warrants/sales https://stock.noler.com/us/stock/arno-therapeutics-inc/interest-and-debt-expense https://stock.noler.com/us/stock/arno-therapeutics-inc/interest-expense https://stock.noler.com/us/stock/arno-therapeutics-inc/interest-expense-on-debt https://stock.noler.com/us/stock/arno-therapeutics-inc/interest-expense-other https://stock.noler.com/us/stock/arno-therapeutics-inc/interest-paid https://stock.noler.com/us/stock/arno-therapeutics-inc/interest-payable-current-and-noncurrent https://stock.noler.com/us/stock/arno-therapeutics-inc/investing-cash-flow https://stock.noler.com/us/stock/arno-therapeutics-inc/investment-income-interest https://stock.noler.com/us/stock/arno-therapeutics-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/arno-therapeutics-inc/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/arno-therapeutics-inc/late-filing-notices-nt-10-q https://stock.noler.com/us/stock/arno-therapeutics-inc/leasehold-improvements-gross https://stock.noler.com/us/stock/arno-therapeutics-inc/level-3-liability-change https://stock.noler.com/us/stock/arno-therapeutics-inc/level-3-liability-gain-loss-included-in-earnings https://stock.noler.com/us/stock/arno-therapeutics-inc/level-3-liability-issues https://stock.noler.com/us/stock/arno-therapeutics-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/arno-therapeutics-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/arno-therapeutics-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/arno-therapeutics-inc/net-change-in-cash https://stock.noler.com/us/stock/arno-therapeutics-inc/net-income https://stock.noler.com/us/stock/arno-therapeutics-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/arno-therapeutics-inc/noncash-or-part-noncash-acquisition-value-of-assets-acquired https://stock.noler.com/us/stock/arno-therapeutics-inc/operating-cash-flow https://stock.noler.com/us/stock/arno-therapeutics-inc/operating-expenses https://stock.noler.com/us/stock/arno-therapeutics-inc/operating-income https://stock.noler.com/us/stock/arno-therapeutics-inc/operating-lease-payments-due https://stock.noler.com/us/stock/arno-therapeutics-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/arno-therapeutics-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/arno-therapeutics-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/arno-therapeutics-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/arno-therapeutics-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/arno-therapeutics-inc/other-accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/arno-therapeutics-inc/other-employee-related-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/arno-therapeutics-inc/other-expenses https://stock.noler.com/us/stock/arno-therapeutics-inc/other-income https://stock.noler.com/us/stock/arno-therapeutics-inc/other-noncash-expense https://stock.noler.com/us/stock/arno-therapeutics-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/arno-therapeutics-inc/other-receivables-net-current https://stock.noler.com/us/stock/arno-therapeutics-inc/paid-in-capital-convertible-debt-with-conversion-feature https://stock.noler.com/us/stock/arno-therapeutics-inc/paid-in-capital-other https://stock.noler.com/us/stock/arno-therapeutics-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/arno-therapeutics-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/arno-therapeutics-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/arno-therapeutics-inc/paid-in-kind-interest https://stock.noler.com/us/stock/arno-therapeutics-inc/payments-of-financing-costs https://stock.noler.com/us/stock/arno-therapeutics-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/arno-therapeutics-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/arno-therapeutics-inc/pension-contributions https://stock.noler.com/us/stock/arno-therapeutics-inc/preferred-shares-facts https://stock.noler.com/us/stock/arno-therapeutics-inc/preferred-stock-dividends-income-statement-impact https://stock.noler.com/us/stock/arno-therapeutics-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/arno-therapeutics-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/arno-therapeutics-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/arno-therapeutics-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/arno-therapeutics-inc/preferred-stock-value https://stock.noler.com/us/stock/arno-therapeutics-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/arno-therapeutics-inc/prepaid-expense-current https://stock.noler.com/us/stock/arno-therapeutics-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/arno-therapeutics-inc/proceeds-from-issuance-of-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/arno-therapeutics-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/arno-therapeutics-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/arno-therapeutics-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/arno-therapeutics-inc/proceeds-from-related-party-debt https://stock.noler.com/us/stock/arno-therapeutics-inc/proceeds-from-repayments-of-related-party-debt https://stock.noler.com/us/stock/arno-therapeutics-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/arno-therapeutics-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/arno-therapeutics-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/arno-therapeutics-inc/property-plant-equipment https://stock.noler.com/us/stock/arno-therapeutics-inc/public-float https://stock.noler.com/us/stock/arno-therapeutics-inc/purchase-commitment-remaining-minimum-amount-committed https://stock.noler.com/us/stock/arno-therapeutics-inc/registration-payment-arrangement-maximum-potential-consideration https://stock.noler.com/us/stock/arno-therapeutics-inc/repayments-of-long-term-capital-lease-obligations https://stock.noler.com/us/stock/arno-therapeutics-inc/repayments-of-notes-payable https://stock.noler.com/us/stock/arno-therapeutics-inc/research-and-development https://stock.noler.com/us/stock/arno-therapeutics-inc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/arno-therapeutics-inc/restricted-cash-and-cash-equivalents-noncurrent https://stock.noler.com/us/stock/arno-therapeutics-inc/retained-earnings https://stock.noler.com/us/stock/arno-therapeutics-inc/sale-of-stock-consideration-received-on-transaction https://stock.noler.com/us/stock/arno-therapeutics-inc/sale-of-stock-number-of-shares-issued-in-transaction https://stock.noler.com/us/stock/arno-therapeutics-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/arno-therapeutics-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/arno-therapeutics-inc/sec-filings-10-k https://stock.noler.com/us/stock/arno-therapeutics-inc/sec-filings-10-q https://stock.noler.com/us/stock/arno-therapeutics-inc/sec-filings-10ksb https://stock.noler.com/us/stock/arno-therapeutics-inc/sec-filings-10qsb https://stock.noler.com/us/stock/arno-therapeutics-inc/sec-filings-15-12g https://stock.noler.com/us/stock/arno-therapeutics-inc/sec-filings-8-a12g https://stock.noler.com/us/stock/arno-therapeutics-inc/sec-filings-8-k https://stock.noler.com/us/stock/arno-therapeutics-inc/sec-filings-ct-order https://stock.noler.com/us/stock/arno-therapeutics-inc/sec-filings-def-14a https://stock.noler.com/us/stock/arno-therapeutics-inc/sec-filings-def-14c https://stock.noler.com/us/stock/arno-therapeutics-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/arno-therapeutics-inc/sec-filings-pre-14c https://stock.noler.com/us/stock/arno-therapeutics-inc/sec-filings-sb-2 https://stock.noler.com/us/stock/arno-therapeutics-inc/sec-filings-sc-14f1 https://stock.noler.com/us/stock/arno-therapeutics-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/arno-therapeutics-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/arno-therapeutics-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/arno-therapeutics-inc/secondary-offerings-form-rw https://stock.noler.com/us/stock/arno-therapeutics-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/arno-therapeutics-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/arno-therapeutics-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/arno-therapeutics-inc/security-deposit https://stock.noler.com/us/stock/arno-therapeutics-inc/share-price https://stock.noler.com/us/stock/arno-therapeutics-inc/shareholders-equity https://stock.noler.com/us/stock/arno-therapeutics-inc/shares-authorized https://stock.noler.com/us/stock/arno-therapeutics-inc/shares-issued https://stock.noler.com/us/stock/arno-therapeutics-inc/shares-issued-price-per-share https://stock.noler.com/us/stock/arno-therapeutics-inc/shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/arno-therapeutics-inc/shares-issued-shares-conversion-of-units https://stock.noler.com/us/stock/arno-therapeutics-inc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/arno-therapeutics-inc/significant-purchase-commitment-remaining-minimum-amount-committed https://stock.noler.com/us/stock/arno-therapeutics-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/arno-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/arno-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/arno-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/arno-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/arno-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/arno-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/arno-therapeutics-inc/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/arno-therapeutics-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/arno-therapeutics-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/arno-therapeutics-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/arno-therapeutics-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/arno-therapeutics-inc/stock-award-other-share-increase-decrease https://stock.noler.com/us/stock/arno-therapeutics-inc/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/arno-therapeutics-inc/stock-award-shares-issued-in-period https://stock.noler.com/us/stock/arno-therapeutics-inc/stock-based-compensation https://stock.noler.com/us/stock/arno-therapeutics-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/arno-therapeutics-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/arno-therapeutics-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/arno-therapeutics-inc/stock-issued-shares-issued-shares-other https://stock.noler.com/us/stock/arno-therapeutics-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/arno-therapeutics-inc/stock-issued-shares-issued-value-conversion-of-units https://stock.noler.com/us/stock/arno-therapeutics-inc/stock-issued-shares-issued-value-issued-for-cash https://stock.noler.com/us/stock/arno-therapeutics-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/arno-therapeutics-inc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/arno-therapeutics-inc/stock-issued-shares-issued-value-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/arno-therapeutics-inc/stock-issued-shares-issued-value-stock-dividend https://stock.noler.com/us/stock/arno-therapeutics-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/arno-therapeutics-inc/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/arno-therapeutics-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/arno-therapeutics-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/arno-therapeutics-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/arno-therapeutics-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/arno-therapeutics-inc/stock-options-grants-in-period https://stock.noler.com/us/stock/arno-therapeutics-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/arno-therapeutics-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/arno-therapeutics-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/arno-therapeutics-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/arno-therapeutics-inc/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/arno-therapeutics-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/arno-therapeutics-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/arno-therapeutics-inc/tax-rate-reconciliation-nondeductible-expense-other https://stock.noler.com/us/stock/arno-therapeutics-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/arno-therapeutics-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/arno-therapeutics-inc/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/arno-therapeutics-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/arno-therapeutics-inc/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/arno-therapeutics-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/arno-therapeutics-inc/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/arno-therapeutics-inc/total-assets https://stock.noler.com/us/stock/arno-therapeutics-inc/total-liabilities https://stock.noler.com/us/stock/arno-therapeutics-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/arno-therapeutics-inc/total-long-term-debt https://stock.noler.com/us/stock/arno-therapeutics-inc/unamortized-debt-issuance-expense https://stock.noler.com/us/stock/arno-therapeutics-inc/unrealized-gain-loss-on-derivatives https://stock.noler.com/us/stock/arno-therapeutics-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/arno-therapeutics-inc/warrants-and-rights-outstanding https://stock.noler.com/us/stock/arno-therapeutics-inc/weighted-average-number-of-share-outstanding-basic-and-diluted